Dusseldorf - Delayed Quote EUR
Verastem Inc. R (2VSA.DU)
6.15
-0.20
(-3.15%)
As of 8:12:10 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-104,771
-104,771
-86,460
-63,673
-53,502
Investing Cash Flow
59,972
59,972
-44,447
66,185
87
Financing Cash Flow
54,782
54,782
134,194
51,784
6,885
End Cash Position
89,059
89,059
79,076
75,789
21,493
Interest Paid Supplemental Data
3,774
3,774
3,361
1,536
1,007
Capital Expenditure
-28
-28
--
--
-196
Issuance of Capital Stock
14,221
14,221
119,519
27,354
6,723
Issuance of Debt
--
--
14,918
24,148
--
Repayment of Debt
-150
-150
-300
--
--
Repurchase of Capital Stock
--
--
--
--
-925
Free Cash Flow
-104,799
-104,799
-86,460
-63,673
-53,698
12/31/2021 - 2/6/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
3G0.BE Altimmune Inc
4.3900
-0.48%
473A.SG Adaptimmune Therapeutics PLC
0.2200
-2.65%
PH4.DU CStone Pharmaceuticals
0.3300
+2.48%
IMR.SG AC Immune SA
1.3560
0.00%
F6T.SG Fate Therapeutics Inc
1.1470
-4.18%
MDG1.F Medigene AG
0.1685
-23.06%
TBPH Theravance Biopharma, Inc.
9.45
+1.50%
OCS Oculis Holding AG
17.89
+0.62%
VOR Vor Biopharma Inc.
0.7591
+8.13%
SCPH scPharmaceuticals Inc.
2.6000
-0.38%